We serve Chemical Name:dl-2-methylglutamic acid CAS:71-90-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:dl-2-methylglutamic acid
CAS.NO:71-90-9
Synonyms:EINECS 200-768-9;DL-2-METHYLGLUTAMIC ACID;D,L-2-METHYLGLUTAMIC ACID HEMIHYDRATE;A-methyl-dl-glutamic acid hydrate;2-amino-2-methyl-glutaric acid;2-methylglutamic acid;MFCD00149281;DL-2-Me-Glu-OH;2-METHYL-DL-GLUTAMIC ACID;DL-methylglutamic acid hemihydrate
Molecular Formula:C6H11NO4
Molecular Weight:161.15600
HS Code:2922499990
Physical and Chemical Properties:
Melting point:160ºC (dec.)(lit.)
Boiling point:329.3ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:100.62000
Exact Mass:161.06900
LogP:0.35350
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like EINECS 200-768-9 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DL-methylglutamic acid hemihydrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methylglutamic acid Use and application,DL-2-Me-Glu-OH technical grade,usp/ep/jp grade.
Related News: McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 5-(2-ethylbutoxy)-3-(2-(propylthio)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine manufacturers “We were all surprised by the speed at which the oncology market grew in China,” Dunoyer said on the call. “Even if we don’t expect rare disease to grow at the same speed, it is likely that the speed at which the rare disease grows in China is going to be faster than other markets of the world.” 2-morpholin-4-ylmethylsulfanyl-3-naphthalen-1-yl-acrylic acid suppliers The outlay will be used to grow Takeda’s portfolio of treatments and boost capacity to manufacture additional products for the rare disease community, Stephen Hatke, Takeda’s Thousand Oaks site head, said in a YouTube video about the expansion. The company didn’t name the specific products it plans to make there. (Z)-4-(4-bromophenyl)-2-(2-(diphenylmethylene)hydrazineyl)-4-oxobut-2-enoic acid vendor & factory.
